Shandong Weigao Group Medical Polymer Company Limited

Shandong Weigao Group Medical Polymer Company Limited

SHWGF

$0.40

Updated: 23/09/2026, 17:07:12

Market Cap
$1.78B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
CN
Stock valuation chart
One-year closing share-price history for SHWGF
Company Profile

Shandong Weigao Group Medical Polymer Company Limited, established in Weihai, People's Republic of China, in 2000, operates as a comprehensive entity focused on the research, development, manufacturing, and sale of a wide array of medical devices, primarily single-use, across the PRC. The company's operations are structured into several distinct segments, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, and Blood Management Products. Its extensive product portfolio includes essential medical consumables such as infusion devices for both vascular and non-vascular access, infusion sets, syringes, puncture needles, and specialized clinical collection kits. Shandong Weigao also provides wound care solutions like sutures and healing dressings, alongside equipment for blood collection, storage, separation, and sterilization. Beyond these, the company's offerings encompass prefilled and pre-flush syringes, blood glucose testing devices, a full range of anesthesia consumables (general, local, and auxiliary), ICU equipment, and surgical instruments for both open and minimally invasive procedures. It is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, implantation materials, and artificial organs. Furthermore, the company manufactures medical PVC granules, various plastic packing materials, carton boxes, industrial automation equipment, molds, and hemodialysis equipment, encompassing Type I, Type II, and Type III medical devices. Complementing its core manufacturing, Shandong Weigao extends its services to finance leasing and factoring, wholesale distribution of various medical devices (including surgical and other disposable products), asset management, enterprise consulting, and logistics and storage. The company also engages in exporting its products, which are marketed under well-known brands such as Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing. Its diverse clientele includes hospitals, blood stations, other medical units, and distributors.

USD
OTC
CEO: Rinan Cong
Employees: 13,307
https://www.weigaogroup.com
Asset Summaries
Latest generated summaries for SHWGF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SHWGF.
Share price
$0.40
Market cap
$1.78B
Exchange
OTC
Currency
USD
CEO
Rinan Cong
Employees
13,307
IPO date
08/06/2010
Beta
0.366
Last dividend
$0.00
Day range
$0.40 – $0.43
52-week range
$0.40 – $0.76
1-day performance
0.00%
1-year performance
0.00%
Current drawdown (1Y)
-47.37%
CIK
N/A
CUSIP
N/A
ISIN
CNE100000171
Created
07/12/2025, 14:14:10
Last update
23/09/2026, 17:07:12

Track Shandong Weigao Group Medical Polymer Company Limited with an AI analyst

See which prediction-market events move SHWGF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SHWGF from your Railway `news_articles` table.

No news found for this symbol.